Omni Partners’s Vicarious Surgical RBOT Stock Holding History
Bought
Maintained
Sold
Other funds holding RBOT
PAMP
AC
RIA
PC
GCL
AC
SCM
Omni Partners's RBOT Position: Q1 2021 in Review
Omni Partners reduced its Vicarious Surgical (RBOT) stake by 65% in Q1 2021, selling an estimated $2.29M and leaving 4,095 shares worth $1.22M. The position accounts for 0.06% of the portfolio, ranked #148.
Omni Partners first reported a position in RBOT in Q4 2020 and has held it in 2 quarters since. The position peaked at $3.53M in Q4 2020. 70 funds tracked by Wall St. Rank hold RBOT as of Q1 2021.
- Omni Partners held 4,095 shares of Vicarious Surgical worth $1.22M as of Q1 2021.
- Omni Partners sold 7,495 Vicarious Surgical shares in Q1 2021, an estimated $2.29M.
- Vicarious Surgical made up 0.06% of Omni Partners's portfolio in Q1 2021, its #148 holding.
- Omni Partners first reported a position in Vicarious Surgical in Q4 2020 and has held it in 2 quarters since.
- Omni Partners's Vicarious Surgical position peaked at $3.53M in Q4 2020.
- 70 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2021.
Based on Omni Partners's 13F filing for Q1 2021, filed 17 May 2021.